Skip to main content
Tech.euFundingExplorerBeta

Qbic II

Investor profile

Venture capital

Qbic II has backed 3 European tech companies across 3 funding rounds between 2021 and 2025, joining rounds totalling €63M. Most active in Healthtech and Hardware. Data as of 4 Nov 2026.

Deals
3
distinct rounds
Companies
3
backed
Active span
2021–2025
5 yrs
Total round €
€63M
sum of rounds joined

Deals by year

distinct rounds / year
Qbic II — deals by year — interactive chart.
Data table
Qbic II — deals by year
20211
20221
20251

Top sectors

by deals
Qbic II — top sectors — interactive chart.
Data table
Qbic II — top sectors
Healthtech2
Hardware1

Stages

by deals
Qbic II — stages — interactive chart.
Data table
Qbic II — stages
Other2
Series B1

Countries

by deals
Qbic II — countries — interactive chart.
Data table
Qbic II — countries
Belgium3

Co-investment network

shared rounds
Co-investment network — interactive chart.
Qbic II — 3 dealsQbic IIAckermans & van Haaren (AvH) — 1 shared deals · click to openAckermans & van Haaren (AvH)Athos Capital — 1 shared deals · click to openAthos CapitalBiocodex — 1 shared deals · click to openBiocodexBNP Paribas Fortis Private Equity — 1 shared deals · click to openBNP Paribas Fortis Private Equityimec.istart — 1 shared deals · click to openimec.istartIndustrya — 1 shared deals · click to openIndustryaInnovation Fund — 1 shared deals · click to openInnovation FundNovalis Biotech Acceleration fund — 1 shared deals · click to openNovalis Biotech Acceleration fundOMX Europe Venture Fund (OMX) — 1 shared deals · click to openOMX Europe Venture Fund (OMX)SFPIM — 1 shared deals · click to openSFPIMUniversity of Antwerp — 1 shared deals · click to openUniversity of AntwerpVIB — 1 shared deals · click to openVIB

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
MRM HealthBelgium1€55M
TrinceBelgium1€4.0M
AloxyBelgium1€3.8M

Biggest deals

top 10 by amount
CompanyStageAmountDate
MRM HealthSeries B€55M2025-09
TrinceOther€4.0M2021-12
AloxyOther€3.8M2022-06
← Back to investors